Interactive overview of primary, secondary, conjugated, sulfated, and muricholic bile acids measured by the
assay, with pathway-level context for liver function, gut microbiome activity, FXR/TGR5 signaling, and
metabolic regulation.
Explore the bile acid pathway
Explore 17 assay targets on a full-width pathway map. Select a compound to highlight its location and review biological context beneath the graphic.
Comprehensive profiling of primary, secondary, conjugated, sulfated, and muricholic bile acids associated
with liver function, gut microbiome activity, FXR/TGR5 signaling, and metabolic regulation.
Hover over a compound for a quick summary. Click any bile acid name to view
biological details and PubChem links.
Select an analyte above or click its labeled box on the pathway. Only the selected compound is highlighted; details appear below.
Selected bile acid
Taurochenodeoxycholic Acid (TCDCA)
TCDCA is a taurine-conjugated form of chenodeoxycholic acid produced in the liver. It
helps represent hepatic bile acid synthesis, enterohepatic circulation, and bile acid signaling activity.
Useful for interpreting primary bile acid production, conjugation capacity, bile
flow, and gut-liver axis activity.
Assay value
Measured as part of the bile acid panel and interpreted alongside CDCA, GCDCA, TCA,
and secondary bile acids.
This graphic is intended as customer-facing biological context, not an exhaustive metabolic map. The measured
compounds are highlighted, while supporting enzymes, receptors, and biological outcomes provide interpretation for
study planning and result discussion.
Assay targets may be below limits of detection or quantitation depending on the sample type and study.
